Waud announces launch of Pharma Services Platform, acquisition of BioBridges

Overview

Deal Type Mergers & Acquisitions
Client & Transactional Partners Waud Capital
BioBridges
Our Role Buy-Side Advisor

Summary

Cain Brothers, a division of KeyBanc Capital Markets, served as the exclusive financial advisor to Waud Capital Partners in connection with the acquisition of BioBridges by Waud’s new pharma services platform company, PharmAlliance Holdings. Prior to this transaction, BioBridges was a wholly owned subsidiary of Soliant Health, a portfolio company of Olympus Partners.

Based on its deep experience across the pharma services and healthcare staffing continuum, Cain Brothers was engaged to serve as Waud’s financial advisor to assist with deal negotiation, M&A landscaping, carveout considerations, and related industry research.

Based in Chicago, Waud Capital Partners is a leading growth-oriented private equity firm with $4.6 billion in assets under management as of December 31, 2022. Waud Capital seeks to partner with experienced management teams to build market-leading companies within two industries: health care and software and technology. Since its founding in 1993, Waud Capital has completed more than 440 investments, including platform companies and follow-on opportunities.

PharmAlliance is a diversified pharmaceutical and life sciences services provider focused on discovery, development, and commercialization solutions across the drug life cycle to emerging and established pharmaceutical, biotechnology, life sciences, and medical device companies. The company's solutions span a multitude of service offerings, therapeutic areas, and end markets.

BioBridges provides clinical development services to emerging and established pharmaceutical, biotechnology, and medical device companies. Since its inception in 2005, BioBridges has designed and built its proprietary and scalable Career Portfolio® Management model, which engages its professionals to meet the specialized needs of its clients’ clinical programs. This model has stood the test of time in working with over 500 companies since its founding in Cambridge, Massachusetts.

Today, BioBridges serves a national base of clients around the U.S. Its highly skilled professionals collaborate with clients to advance science and produce therapies for patients who need them.

Cain Brothers

Waud launch Pharma Services Platform

KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.

Recent Deals

July 2025

kodiak

a portfolio company of

courtsquare

divested

kodiak partner

to a

Private Investor Consortium

Exclusive Sell-Side Advisor

kodiak-interiors-group-llc
July 2025

beacon

acquired

ascension borgess

from

ascension

Financial Advisor

beacon-health
July 2025

radiology partners

a portfolio company of 

nea

and

whistler capital

$1.815 Billion

Senior Secured Credit Facilities

$900 Million

8.50% First Lien Secured Notes due 2032

Joint Lead Arranger
Joint Bookrunner

radiology-partners
June 2025

allied

$245 Million

Senior Secured Credit Facilities

Debt Advisor

allied

Connect With Us

Find an Expert